Caffeine Orange
featured

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H123006

CAS#: 1632296-13-9

Description: Caffeine Orange is a selective, BODIPY-based fluorescent caffeine chemosensor.

Chemical Structure

img
Caffeine Orange
CAS# 1632296-13-9
Instruction

Theoretical Analysis

Hodoodo Cat#: H123006
Name: Caffeine Orange
CAS#: 1632296-13-9
Chemical Formula: C20H15BF3N3
Exact Mass: 365.13
Molecular Weight: 365.170
Elemental Analysis: C, 65.78; H, 4.14; B, 2.96; F, 15.61; N, 11.51

Price and Availability

Size Price Availability Quantity
5mg USD 450 2 Weeks
Bulk inquiry

Synonym: BODIPY-based fluorescent; Caffeine Orange; Caffeine-Orange

IUPAC/Chemical Name: (E)-5,5-difluoro-3-(2-(5-fluoro-1H-indol-3-yl)vinyl)-1-methyl-5H-5l4,6l4-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinine

InChi Key: AROCVQXCAJKRTJ-GQCTYLIASA-N

InChi Code: InChI=1S/C20H15BF3N3/c1-13-9-17(6-4-14-12-25-19-7-5-15(22)10-18(14)19)27-20(13)11-16-3-2-8-26(16)21(27,23)24/h2-12,25H,1H3/b6-4+

SMILES Code: CC1=C2C=C3C=CC=[N+]3[B-](F)(N2C(/C=C/C4=CNC5=CC=C(C=C45)F)=C1)F

Appearance: To be determined

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 365.17 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Bitter Orange. 2021 Jun 21. PMID: 30000952.


2: Nédélec M, Halson S, Delecroix B, Abaidia AE, Ahmaidi S, Dupont G. Sleep Hygiene and Recovery Strategies in Elite Soccer Players. Sports Med. 2015 Nov;45(11):1547-59. doi: 10.1007/s40279-015-0377-9. PMID: 26275673.


3: Stohs SJ, Badmaev V. A Review of Natural Stimulant and Non-stimulant Thermogenic Agents. Phytother Res. 2016 May;30(5):732-40. doi: 10.1002/ptr.5583. Epub 2016 Feb 9. PMID: 26856274; PMCID: PMC5067548.


4: Nédélec M, Halson S, Abaidia AE, Ahmaidi S, Dupont G. Stress, Sleep and Recovery in Elite Soccer: A Critical Review of the Literature. Sports Med. 2015 Oct;45(10):1387-400. doi: 10.1007/s40279-015-0358-z. PMID: 26206724.


5: Songy B. Adenosine-caffeine: the agonist-antagonist couple for vasodilator stress tests. J Nucl Cardiol. 2023 Apr;30(2):581-584. doi: 10.1007/s12350-022-03107-0. Epub 2022 Sep 19. PMID: 36123567.


6: Shapiro B. Caffeine Restrictions in Inpatient Psychiatric Settings: Precipitating Withdrawal? J Addict Med. 2020 Jul/Aug;14(4):269-271. doi: 10.1097/ADM.0000000000000571. PMID: 31609867.


7: Xu W, Kim TH, Zhai D, Er JC, Zhang L, Kale AA, Agrawalla BK, Cho YK, Chang YT. Make caffeine visible: a fluorescent caffeine "traffic light" detector. Sci Rep. 2013;3:2255. doi: 10.1038/srep02255. PMID: 23877095; PMCID: PMC3719075.


8: Bush JA, Ratamess NA, Stohs SJ, Ellis NL, Vought IT, O'Grady EA, Kuper JD, Kang J, Faigenbaum AD. Acute hematological and mood perception effects of bitter orange extract (p-synephrine) consumed alone and in combination with caffeine: A placebo-controlled, double-blind study. Phytother Res. 2018 Aug;32(8):1593-1607. doi: 10.1002/ptr.6090. Epub 2018 Apr 19. PMID: 29672965.


9: Salcedo J, Kern MJ. Effects of caffeine and theophylline on coronary hyperemia induced by adenosine or dipyridamole. Catheter Cardiovasc Interv. 2009 Oct 1;74(4):598-605. doi: 10.1002/ccd.22030. PMID: 19496111.


10: Ratamess NA, Bush JA, Stohs SJ, Ellis NL, Vought IT, O'Grady EA, Kuper JD, Hasan SB, Kang J, Faigenbaum AD. Acute cardiovascular effects of bitter orange extract (p-synephrine) consumed alone and in combination with caffeine in human subjects: A placebo-controlled, double-blind study. Phytother Res. 2018 Jan;32(1):94-102. doi: 10.1002/ptr.5953. Epub 2017 Oct 19. PMID: 29047215.


11: Lyles MB, Cameron IL. Interactions of the DNA intercalator acridine orange, with itself, with caffeine, and with double stranded DNA. Biophys Chem. 2002 Apr 10;96(1):53-76. doi: 10.1016/s0301-4622(02)00036-4. PMID: 11975993.


12: Mikalsen A, Bertelsen B, Flaten MA. Effects of caffeine, caffeine-associated stimuli, and caffeine-related information on physiological and psychological arousal. Psychopharmacology (Berl). 2001 Oct;157(4):373-80. doi: 10.1007/s002130100841. PMID: 11605096.


13: Higgins JP, Tuttle TD, Higgins CL. Energy beverages: content and safety. Mayo Clin Proc. 2010 Nov;85(11):1033-41. doi: 10.4065/mcp.2010.0381. PMID: 21037046; PMCID: PMC2966367.


14: Stohs SJ, Preuss HG, Shara M. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine. Int J Med Sci. 2012;9(7):527-38. doi: 10.7150/ijms.4446. Epub 2012 Aug 29. PMID: 22991491; PMCID: PMC3444973.


15: Anuchin AM, Iuvs GG. [Comparative analysis of ergogenic efficacy of energy drinks components (caffeine and bitter orange extract) in combination with alcohol]. Vopr Pitan. 2014;83(1):61-6. Russian. PMID: 25059058.


16: Clarke ND, Duncan MJ. Effect of Carbohydrate and Caffeine Ingestion on Badminton Performance. Int J Sports Physiol Perform. 2016 Jan;11(1):108-15. doi: 10.1123/ijspp.2014-0426. Epub 2015 May 26. PMID: 26024551.


17: McGuffin M. Effect on heart rate of bitter orange, caffeine, and exercise. Am J Med. 2007 Jan;120(1):e19; author reply e21. doi: 10.1016/j.amjmed.2005.12.031. PMID: 17208064.


18: Ghosh AK, Ghosh C, Gupta A. A simple approach to detect caffeine in tea beverages. J Agric Food Chem. 2013 Apr 24;61(16):3814-20. doi: 10.1021/jf400293u. Epub 2013 Apr 10. PMID: 23544959.


19: Flaten MA, Blumenthal TD. Caffeine-associated stimuli elicit conditioned responses: an experimental model of the placebo effect. Psychopharmacology (Berl). 1999 Jul;145(1):105-12. doi: 10.1007/s002130051038. PMID: 10445379.


20: Pawar RS, Sagi S, Leontyev D. Analysis of bitter orange dietary supplements for natural and synthetic phenethylamines by LC-MS/MS. Drug Test Anal. 2020 Sep;12(9):1241-1251. doi: 10.1002/dta.2871. Epub 2020 Jun 28. PMID: 32497396.